Filing Details
- Accession Number:
- 0001479290-19-000036
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-19 20:58:46
- Reporting Period:
- 2019-03-15
- Accepted Time:
- 2019-03-19 20:58:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1479290 | Revance Therapeutics Inc. | RVNC | Pharmaceutical Preparations (2834) | 770551645 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1744573 | Cyril Allouche | C/O Revance Therapeutics, Inc. 7555 Gateway Blvd Newark CA 94560 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-03-15 | 252 | $15.45 | 6,898 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2019-03-18 | 498 | $15.48 | 6,400 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares withheld by and surrendered to the issuer on March 15, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock Award ("RSA") for 2,250 shares. The RSA vests in three equal annual installments from March 15, 2018, subject to Mr. Allouche's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mr. Allouche.
Billionaire Hedge Funds
